🇺🇸 FDA
Patent

US 6162815

RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof

expired A61KA61K45/06A61K8/368

Quick answer

US patent 6162815 (RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof) held by Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma
Grant date
Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K45/06, A61K8/368, A61K8/445, A61K8/46